Mavacamten: a promising new target drug for the treatment of hypertrophic cardiomyopathy.
10.3760/cma.j.cn112148-20200930-00781
- Author:
Yi Peng ZHANG
1
;
Ben HE
1
Author Information
1. Department of Cardiology, Shanghai Chest Hospital,Shanghai Jiao Tong University, Shanghai 200030, China.
- Publication Type:Journal Article
- MeSH:
Benzylamines;
Cardiomyopathy, Hypertrophic/drug therapy*;
Humans;
Pharmaceutical Preparations;
Uracil/analogs & derivatives*
- From:
Chinese Journal of Cardiology
2021;49(4):310-313
- CountryChina
- Language:Chinese
